by admin | May 6, 2020 | Press Releases
Researchers at the University of Miami Miller School of Medicine have validated a biomarker for amyotrophic lateral sclerosis (ALS) – a finding that could lead to faster and more efficient clinical trials to develop potential new therapies. “Therapy development for...
by admin | Oct 4, 2019 | Press Releases
An international research consortium led by investigators at the University of Miami Miller School of Medicine has made significant progress in understanding amyotrophic lateral sclerosis (ALS) and related diseases since its founding in 2014. Now the Clinical...
by admin | Jul 18, 2019 | Press Releases
An international phase III clinical trial evaluating the drug Arimoclomol for the treatment of amyotrophic lateral sclerosis (ALS) has reached full enrollment, as reported by a University of Miami Miller School of Medicine researcher. The current phase III trial...
Recent Comments